GLP-1 medicines like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are genuinely powerful for diabetes and weight — but they are not for everyone. Some people should not take them at all; others need careful checks first. This is a safety and eligibility guide, not a prescription.
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy, oral Rybelsus and the new Indian generics) and tirzepatide (Mounjaro) — can transform blood-sugar control and weight. But like any effective medicine, they have people they suit and people they don’t. Knowing the difference is the whole point of a proper assessment before starting.
GLP-1 medicines may be considered in selected people with type 2 diabetes, obesity, or overweight alongside a weight-related health problem — high blood pressure, fatty liver, PCOS, high cholesterol or insulin resistance. The decision rests on medical need, not simply a wish to lose weight.
| May be considered | Usually not appropriate |
|---|---|
| Type 2 diabetes with excess weight or poor sugar control | Normal BMI with a cosmetic weight-loss goal |
| Obesity with fatty liver, BP, cholesterol or sleep-apnoea risk | Pregnancy, breastfeeding or trying to conceive soon |
| Overweight with metabolic complications | Personal/family history of medullary thyroid cancer or MEN 2 |
| Ready for follow-up, diet and monitoring | Self-injection without medical supervision |
If any of these apply to you, the safe answer is usually a clear no — and a doctor can suggest other ways to manage weight or sugar.
For many people a GLP-1 isn’t ruled out, but it needs individual assessment and monitoring rather than a casual start.
| Situation | Why it matters |
|---|---|
| Past pancreatitis | Needs careful risk assessment and monitoring |
| Gallstones / gallbladder disease | Rapid weight loss can increase gallstone risk |
| Severe gut problems / gastroparesis | These drugs slow the stomach further |
| On insulin or sulfonylureas | Higher low-sugar risk — doses often need adjusting |
| Kidney concerns / dehydration risk | Vomiting and poor intake can stress the kidneys |
| History of an eating disorder | Appetite-suppressing drugs need caution and support |
If you have diabetes and already take insulin, a sulfonylurea (glimepiride, gliclazide, glipizide) or several sugar medicines, a GLP-1 should be started only with proper review — those medicines often need adjusting to avoid low sugar.
As a diabetologist, Dr. Manuj assesses diabetic patients differently from non-diabetic weight-loss patients — reviewing your sugar readings, HbA1c, current medicines, kidney function and hypoglycaemia risk before deciding dose and follow-up.
GLP-1 medicines are not used in pregnancy or while breastfeeding. If you might become pregnant, this needs planning: semaglutide is generally stopped about two months before trying to conceive, because it stays in the body for weeks.
GLP-1 medicines are licensed for type 2 diabetes and for obesity, or overweight with a weight-related health problem — typically guided by your BMI and health risk, not by how you’d like to look. Using them at a normal weight, for cosmetic reasons, or without medical supervision is unsafe.
Buying from a gym, salon or online seller adds more risk: wrong storage, wrong dose, fake or unauthorised supply, poor injection technique, and no one to call if side effects appear. The injection alone isn’t the treatment — eligibility check, dose selection, side-effect counselling, follow-up and monitoring are.
It’s a powerful prescription medicine that changes how your gut, appetite and sugar behave. For the right person it’s excellent; for the wrong person it can cause real harm. The difference isn’t willpower or money — it’s your medical history, which a short assessment sorts out.
If you’re already on a GLP-1, mild nausea or reduced appetite can be expected — but some symptoms should never be brushed off as “normal side effects.”
A 30-second guide to whether a GLP-1 is even worth discussing with a doctor. It does not diagnose you or clear you for treatment — it simply points you to the right next step.
1. Why are you considering a GLP-1 medicine?
2. Do any of these apply to you? (tick all that apply)
3. Do any of these apply to you? (tick all that apply)
At Nirvana Clinic, Greater Noida, Dr. Manuj Sondhi assesses whether a GLP-1 is appropriate — checking your BMI and health risk, diabetes status, thyroid/pancreas/gallbladder history, pregnancy plans, kidney function and your other medicines — before any treatment is considered, and with proper follow-up if it is.
Thinking about treatment? See medical weight loss in Greater Noida, the honest guide to generic semaglutide, or — if you’re already on one — can I stop Mounjaro or Ozempic?
With 15+ years in metabolic and internal medicine, Dr. Manuj Sondhi treats diabetes, obesity and weight-related conditions at Nirvana Clinic, Greater Noida (Delhi NCR). He uses GLP-1 medicines where they genuinely fit — after a proper eligibility check and with real follow-up — rather than as a one-size prescription.
The safe first step isn't a pharmacy or a gym — it's an eligibility assessment. Let Dr. Manuj Sondhi check whether Mounjaro, Ozempic or semaglutide fits your health, and what to do if it doesn't.
Nirvana Clinic · Shop GF-93, Sun Twilight Mall, Opp. Delta 1 Metro Station, Greater Noida 201308